Images courtesy of InSilicoTrials A new project is exploring the use of simulation during development of treatments for osteoporosis, tuberculosis, multiple sclerosis, coronary stenosis, cerebral aneurysms, mammary carcinoma, and COVID-19 infection.
Modeling and simulation are being put to work toward tackling some big healthcare concerns. In January a project coordinated by the University of Bologna and funded by the European Union’s Horizon 2020 kicked off to accelerate adoption of modeling and simulation technologies for medical device and drug development and regulatory assessment, according to project coordinator Marco Viceconti, who serves as professor at Alma Mater Studiorum University of Bologna.
Called In Silico World (ISW), the project takes its name from the online community of practice of the same name, recently launched by the University of Bologna, including experts and all relevant categories of stakeholders of in silico medicine. InSilic